Coronavirus (SARS CoV-2) the cause of COVID-19 a fatal disease emerged from Wuhan, a large city in the Chinese province of Hubei in December 2019.

pharmacology

Description

ABSTRACT:

Background: Coronavirus (SARS CoV-2) the cause of COVID-19 a fatal disease emerged from Wuhan, a large city in the Chinese province of Hubei in December 2019.

Main body of abstract: World health organization declared this as a pandemic due to spread of the virus to other countries inside and outside Asia. Initial confirmation of the pandemic shows patient exposure to Huanan seafood market. It is found that bats might be a major hosts for spread of coronaviruses via unknown intermediate host. The human to human transfer has become a great concern due to one of the major reasons that is asymptomatic carriers or silent spreaders. Although many clinical trials are underway but no data is obtained regarding prophylactic treatment for COVID-19.

Conclusion: The most effective weapon is prevention and precaution to avoid spread of the pandemic. In this current review we outline pathogenesis, diagnosis, treatment, ongoing clinical trials, prevention and precautions. We also discuss the impact of pandemic worldwide and challenges which can help to overcome the fatal disease in future.

KEYWORDS: COVID-19, SARS-CoV-2, Lifecycle, Pathogenesis, Prevention, Clinical trials.

 BACKGROUND

Coronaviruses (CoVs) are enveloped positive-sense RNA viruses; they are characterized by club-like spikes that project from their surface, and have an unusually large RNA genome. They show a unique replication strategy. The term “coronavirus” is derived from the “crown”-like morphology. Coronaviruses cause a variety of diseases in animals and birds and potentially lethal human respiratory infections [[i]].

Coronavirus is one of the major pathogens that primarily target the human respiratory system. Previous outbreaks of coronaviruses CoVs include the severe acute respiratory syndrome (SARS-CoV) and the Middle East respiratory syndrome (MERS-CoV) which have been previously characterized as agents that are a great public health threat [[ii]].



1. Helena Jane Maier et al. (2015). Coronaviruses: Methods and Protocols. Methods in Molecular Biology Springer. Vol. 1282. DOI: 10.1007/978-1-4939-2438-7.

[ii] . Hussin A. Rothana; Siddappa N. Byrareddy; (Feb 2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity 102433 Elsevier. 109. DOI: https://doi.org/10.1016/j.jaut.2020.102433.


Related Questions in pharmacology category